Hawaii Biotech CEO Len Firestone Steps Down; Carolyn Weeks-Levy Named Interim CEO

Hi, Biotech is an independent publication with no affiliation with Hawaii Biotech, Inc. This page preserves a historical record from the company's original press archive, republished for research and archival purposes. Copyright in the original material remains with its original owner.

Hawaii Biotech, Inc.

FOR IMMEDIATE RELEASE

Contact: Robert F. Kay 808-732-0631 Email: rkay@lava.net

Hawaii Biotech CEO Len Firestone Steps Down Carolyn Weeks-Levy named Interim Senior Executive

Honolulu, Hawaii, April 4, 2007 - The Board of Directors of Hawaii Biotech today announced that Dr. Leonard Firestone has stepped down as Ch ief Executive Officer a nd Director, effective immediately. Dr. Carolyn Weeks-Levy, the comp any's V.P. & Chief Scientific Officer , will act as interim Senior Executive of the Company. The Co mpany also announced that Dr. Steven Mento, a current member of the Board, has been appointed by the Board as its Chairman. "Len Firestone came to Hawaii Biotech to revitalize the company's vaccine efforts. During his tenure, the company has made significant progress in the development of nov el vaccines to treat important infectious diseases. We thank Len for his efforts," said Dr. Weeks-Levy. "While we appreciate the contributions made by Dr . Firestone," said Dr. Mento, "the strategic vision of the CEO and Board diverged and there was mutual agreement that there was a need for change." Dr. Carolyn Weeks-Levy who has over 20 years experience in research ma nagement, biotechnology and vaccine research, will retain her responsibilities as Chief Scientist of the company. Hawaii Biotech, Inc. is a privately held biotechn ology company focused on research and development of vaccines for emerging infectious diseases including West Nile virus and Influenza. For more information, please visit http://www.hibiotech.com